These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 9869612

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Clinical significance of factor V Leiden and prothrombin G20210A-mutations in cerebral venous thrombosis - comparison with arterial ischemic stroke.
    Beye A, Pindur G.
    Clin Hemorheol Microcirc; 2017; 67(3-4):261-266. PubMed ID: 28869458
    [Abstract] [Full Text] [Related]

  • 23. Thrombophilic factor analysis in cirrhotic patients with portal vein thrombosis.
    Saugel B, Lee M, Feichtinger S, Hapfelmeier A, Schmid RM, Siveke JT.
    J Thromb Thrombolysis; 2015 Jul; 40(1):54-60. PubMed ID: 25115839
    [Abstract] [Full Text] [Related]

  • 24. Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population.
    Finan RR, Tamim H, Ameen G, Sharida HE, Rashid M, Almawi WY.
    Am J Hematol; 2002 Dec; 71(4):300-5. PubMed ID: 12447960
    [Abstract] [Full Text] [Related]

  • 25. Combined heterozygosity of factor V leiden and the G20210A prothrombin gene mutation in a patient with cerebral cortical vein thrombosis.
    Liu XY, Gabig TG, Bang NU.
    Am J Hematol; 2000 Jul; 64(3):226-8. PubMed ID: 10861823
    [Abstract] [Full Text] [Related]

  • 26. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
    Emmerich J, Rosendaal FR, Cattaneo M, Margaglione M, De Stefano V, Cumming T, Arruda V, Hillarp A, Reny JL.
    Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
    [Abstract] [Full Text] [Related]

  • 27. Venous thrombosis with both heterozygous factor V Leiden (R507Q) and factor II (G20210A) mutations.
    Bhaijee F, Jordan B, Pepper DJ, Leacock R, Rock WA.
    Clin Lab Sci; 2012 Sep; 25(4):199-205. PubMed ID: 23330508
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Distinct association of factor V-Leiden and prothrombin G20210A mutations with deep venous thrombosis in Tunisia and Lebanon.
    Bouaziz-Borgi L, Almawi WY, Mtiraoui N, Nsiri B, Keleshian SH, Kreidy R, Louzir B, Hezard N, Mahjoub T.
    Am J Hematol; 2006 Aug; 81(8):641-3. PubMed ID: 16823828
    [Abstract] [Full Text] [Related]

  • 31. Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis.
    Amitrano L, Brancaccio V, Guardascione MA, Margaglione M, Iannaccone L, D'Andrea G, Marmo R, Ames PR, Balzano A.
    Hepatology; 2000 Feb; 31(2):345-8. PubMed ID: 10655256
    [Abstract] [Full Text] [Related]

  • 32. [Mutation frequencies of the thrombophilic state genes in Uzbekistan].
    Sadikova ShE, Karimov KhIa, Muminov ShM, Tulakov RP, Boboev KT.
    Tsitol Genet; 2008 Feb; 42(6):50-4. PubMed ID: 19253755
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Portal vein thrombosis associated to prothrombin G20210A mutation and protein C deficiency.
    Mira Y, García del Castillo G, Estellés A, Villa P, Vayá A, Ortuño C, Aznar J.
    Clin Appl Thromb Hemost; 2000 Jul; 6(3):179-80. PubMed ID: 10898280
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Effects of factor V gene G1691A, methylenetetrahydrofolate reductase gene C677T, and prothombin gene G20210A mutations on deep venous thrombogenesis in Behçet's disease.
    Toydemir PB, Elhan AH, Tükün A, Toydemir R, Gürler A, Tüzüner A, Bökesoy I.
    J Rheumatol; 2000 Dec; 27(12):2849-54. PubMed ID: 11128675
    [Abstract] [Full Text] [Related]

  • 37. Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery.
    Wåhlander K, Larson G, Lindahl TL, Andersson C, Frison L, Gustafsson D, Bylock A, Eriksson BI.
    Thromb Haemost; 2002 Apr; 87(4):580-5. PubMed ID: 12008938
    [Abstract] [Full Text] [Related]

  • 38. Combined genetic defect (homogeneity for factor V Leiden and heterogeneity for prothrombin G20210A allele), in a young patient, with recurrent deep vein thrombosis and serious postphlebitic syndrome--a case report.
    Mitsis M, Ioannou H, Eleftheriou A, Nousias V, Basioukas C, Kakosimos G, Batsis C, Vartholomatos G.
    Angiology; 2000 Apr; 51(4):325-9. PubMed ID: 10779003
    [Abstract] [Full Text] [Related]

  • 39. Interaction between the G20210A mutation of the prothrombin gene and oral contraceptive use in deep vein thrombosis.
    Martinelli I, Taioli E, Bucciarelli P, Akhavan S, Mannucci PM.
    Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):700-3. PubMed ID: 10073976
    [Abstract] [Full Text] [Related]

  • 40. Molecular analysis of factor V Leiden, factor V Hong Kong, factor II G20210A, methylenetetrahydrofolate reductase C677T, and A1298C mutations related to Turkish thrombosis patients.
    Dölek B, Eraslan S, Eroğlu S, Kesim BE, Ulutin T, Yalçiner A, Laleli YR, Gözükirmizi N.
    Clin Appl Thromb Hemost; 2007 Oct; 13(4):435-8. PubMed ID: 17911197
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.